Aytu Bioscience Rg

Aytu BioPharma develops and markets innovative ADHD treatments, including Adzenys XR‑ODT and Cotempla XR‑ODT tablets for children and adolescents, plus Metadate CD for broader CNS disorders—positioned to grow in the expanding pediatric pharmaceutical market, based in Denver.

Headquarters: United States (USA)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Manufacturing
Industry: Pharmaceutical Manufacturing

Employees: 82
HQ: Denver

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
AYTU	Aytu Bioscience Rg Cap: 0.0B	EQUITY	NMS	USD	US0547548745	Active	📈